FindTrial
Sign In

To evaluate cost and benefit of dental implant-supported removable denture prosthesis treatment in head and neck cancer patients.

Cost-benefit analysis of dental implant-supported overdenture treatment in head and neck cancer patients. - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072822
Enrollment
40
Registered
2024-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

TATA MEMORIAL HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consecutive, disease-free, consenting 18 – 75 years old head and neck cancer patients of all socio-economic strata who: a) Are planned to receive implant-supported overdenture prosthesis replacing 8 or more missing teeth in the native maxilla/mandible or jaw reconstructed with free fibular flap. b) Patients who have undergone dental implant insertion surgery and planned for implant supported overdenture. c) Patients who shall be using dentures for first time d) Have 12 or more teeth, either natural or prosthetically replaced in the opposite arch. e) Patients who can understand and fill Oral health impact profile questionnaire (OHIP-14) and Liverpool oral rehabilitation questionnaire (LORQOLv3) in English or translated versions.

Exclusion criteria

Exclusion criteria: a) Patients with major intra-oral defects such as total or near total glossectomy. b) Patients who have undergone bite composite resection with or without reconstruction with an osseous flap. c)Patients with posterior segmental mandibulectomy without osseous reconstruction. d) Systemic contraindications for dental implant treatment such as recent myocardial infarction and cerebrovascular accident, uncontrolled diabetes, bleeding disorder, patients on antiresorptive medications and immunocompromised patients. e) Patients who are using implant supported prosthesis and requires replacement of prosthesis

Design outcomes

Primary

MeasureTime frame
1. Total cost of rehabilitation 2. Effectiveness Timepoint: 3+/-1 months after prosthesis fabrication—

Secondary

MeasureTime frame
Mixing Ability TestTimepoint: before prosthesis fabrication and 3-4 months after implant overdenture treatment.;Patient-perceived treatment satisfaction will be evaluated using Liverpool Oral Rehabilitation Questionnaire (LORQv4) scoresTimepoint: before prosthesis fabrication and 3-4 months after implant overdenture treatment.—

Countries

India

Contacts

Public ContactDr Sauptik Ray

Tata Memorial Centre

drsandeepgurav@gmail.com02224177224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026